Association between age-related macular degeneration and risk of incident cancerJunhee Park, Wonyoung Jung, Kyungdo Han, Bongseong Kim, Seung-Yeon Lee, Je Moon Yoon, Dong Hui Lim, Dong Wook Shin
28 February 2024
Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedemaAsad Farooq Durrani, Bita Momenaei, Taku Wakabayashi, Sudheshna Vemula, Saagar A Pandit, Jason Hsu, Allen C Ho, Marc J Spirn, Michael A Klufas, Sunir J Garg, James F Vander, Carl D Regillo, Allen Chiang, Ajay E Kuriyan, Yoshihiro Yonekawa
12 February 2024
Heterogeneity in disease activity, frequency of treatments, and visual outcomes among patients with retinal vein occlusion: relationship between injection need and vision with as-needed ranibizumabRobert B Bhisitkul, Peter A Campochiaro, Steven Blotner, Carlos Quezada-Ruiz, Mimi Liu, Zdenka Haskova
30 January 2024
Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in neovascular age-related macular degeneration in real-world routine (FRB!)Virginia Mares, Ursula Margarethe Schmidt-Erfurth, Oliver Leingang, Philipp Fuchs, Marcio B Nehemy, Hrvoje Bogunovic, Daniel Barthelmes, Gregor S Reiter
29 September 2023
Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIERSriniVas Sadda, David Sarraf, Arshad M Khanani, Ramin Tadayoni, Andrew A Chang, Insaf Saffar, Kinfemichael Gedif, David T Wong
5 September 2023
Characterisation of the vascular anterior surface of type 1 macular neovascularisation after anti-VEGF therapyFederico Corvi, Tommaso Bacci, Giulia Corradetti, Giovanni Staurenghi, David Sarraf, K. Bailey Freund, SriniVas Sadda
10 May 2022
Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort studyKatrine Hartmund Frederiksen, Lonny Stokholm, Peter Hartmund Frederiksen, Christina Mørup Jørgensen, Sören Möller, Ryo Kawasaki, Tunde Peto, Jakob Grauslund
10 May 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialTimothy L Jackson, Cristina Soare, Caroline Petrarca, Andrew Simpson, James E Neffendorf, Robert Petrarca, Katherine Alyson Muldrew, Tunde Peto, Usha Chakravarthy, Luke Membrey, Richard Haynes, Mark Costen, David H W Steel, Riti Desai, Fiona BishopSee the full list of authors
25 February 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C Gillies
25 January 2022
Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendationsManuel Vargas-Peirano, Catalina Verdejo, Laura Vergara-Merino, Cristóbal Loézar, Martin Hoehmann, Javier Pérez-Bracchiglione
14 December 2021